Guardant Health Share Price Today
(NASDAQ: GH)

Name: Guardant Health Share Price Today (NASDAQ: GH) - Guardant Health Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Guardant Health share price is $46.98 & ₹4,070.35 as on 1 Feb 2025, 2.30 'hrs' IST

$46.98

▲

-2.96

(-5.93%)

Market is closed - opens 8 PM, 03 Feb 2025

View live Guardant Health share price in Dollar and Rupees. Guide to invest in Guardant Health stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Guardant Health, along with analyst recommendations, forecasts, and comprehensive financials.

Guardant Health share price movements

Today's Low: $46.76
Today's High: $49.68
$46.98
0.47%
Downside
Day's Volatility :5.87%
Upside
5.43%
52 Weeks Low: $15.81
52 Weeks High: $50.89
$46.98
66.35%
Downside
52 Weeks Volatility :68.93%
Upside
7.68%

Guardant Health (GH) Returns

Period	Guardant Health, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	99.07%	-0.6%	0.0%
6 Months	53.78%	-2.8%	0.0%
1 Year	111.72%	3.3%	0.0%
3 Years	-33.36%	11.6%	-13.7%

Guardant Health (GH) Key Statistics

in dollars & INR

Previous Close	$49.94
Open	$49.77
Today's High	$49.675
Today's Low	$46.76
Market Capitalization	$6.2B
Today's Volume	$2.4M
52 Week High	$50.89
52 Week Low	$15.81
Revenue TTM	$692.3M
EBITDA	$-386.3M
Earnings Per Share (EPS)	$-4.03
Profit Margin	-74.02%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-609.28%

How to invest in Guardant Health Stock (GH) from India?

It is very easy for Indian residents to invest directly in Guardant Health from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Guardant Health stock in both Indian Rupees (INR) and US Dollars (USD). Search for Guardant Health or GH on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Guardant Health or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Guardant Health shares which would translate to 0.018 fractional shares of Guardant Health as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Guardant Health, in just a few clicks!

Returns in Guardant Health (GH) for Indian investors in Rupees

The Guardant Health stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Guardant Health investment value today

Current value as on today

₹2,16,276

Returns

₹1,16,276

(+116.28%)

Returns from Guardant Health Stock

₹1,11,717 (+111.72%)

Dollar Returns

₹4,559 (+4.56%)

Indian investors sentiment towards Guardant Health (GH)

169%

Period: Jan 1, 2025 to Jan 31, 2025. Change in 30 Days versus previous period

Search interest for Guardant Health Stock from India on INDmoney has increased by 169% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Guardant Health

BlackRock Inc
9.26%
Deep Track Capital, LP
4.86%
State Street Corp
2.26%
Temasek Holdings Ltd.
1.69%
Fidelity Management and Research Company
1.19%
Northern Trust Corp
0.86%

Analyst Recommendation on Guardant Health

Buy

83%Buy

16%Hold

0%Sell

Based on 30 Wall street analysts offering stock ratings for Guardant Health(by analysts ranked 0 to 5 stars)

Based on 30 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Guardant Health Stock (GH)

What analysts predicted

Downside of 0.46%

Target:

$46.76

Current:

$46.98

Insights on Guardant Health Stock (Ticker Symbol: GH)

Price Movement
In the last 1 month, GH stock has moved up by 53.8%
Increasing Revenue
Revenue is up for the last 11 quarters, 96.09M → 191.47M (in $), with an average increase of 6.6% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -102.62M → -107.75M (in $), with an average decrease of 5.0% per quarter
GH vs A (3 yr)
In the last 3 years, Agilent Technologies Inc. has given 7.4% return, outperforming this stock by 43.0%

GH Guardant Health Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$90.6M	↑ 81.85%
Net Income	$-85.1M	↑ 2.21%
Net Profit Margin	-93.85%	↑ 73.12%

	FY19	Y/Y Change
Revenue	$214.4M	↑ 136.52%
Net Income	$-67.9M	↓ 20.23%
Net Profit Margin	-31.65%	↑ 62.2%

	FY20	Y/Y Change
Revenue	$286.7M	↑ 33.75%
Net Income	$-246.3M	↑ 262.98%
Net Profit Margin	-85.89%	↓ 54.24%

	FY21	Y/Y Change
Revenue	$373.7M	↑ 30.32%
Net Income	$-384.8M	↑ 56.23%
Net Profit Margin	-102.98%	↓ 17.09%

	FY22	Y/Y Change
Revenue	$449.5M	↑ 20.31%
Net Income	$-654.6M	↑ 70.12%
Net Profit Margin	-145.61%	↓ 42.63%

	FY23	Y/Y Change
Revenue	$563.9M	↑ 25.45%
Net Income	$-479.4M	↓ 26.76%
Net Profit Margin	-85.02%	↑ 60.59%

	Q2 FY23	Q/Q Change
Revenue	$137.2M	↑ 6.55%
Net Income	$-72.8M	↓ 45.5%
Net Profit Margin	-53.06%	↑ 50.68%

	Q3 FY23	Q/Q Change
Revenue	$143.0M	↑ 4.29%
Net Income	$-86.1M	↑ 18.32%
Net Profit Margin	-60.2%	↓ 7.14%

	Q4 FY23	Q/Q Change
Revenue	$155.1M	↑ 8.41%
Net Income	$-187.0M	↑ 117.23%
Net Profit Margin	-120.63%	↓ 60.43%

	Q1 FY24	Q/Q Change
Revenue	$168.5M	↑ 8.67%
Net Income	$-115.0M	↓ 38.52%
Net Profit Margin	-68.24%	↑ 52.39%

	Q2 FY24	Q/Q Change
Revenue	$177.2M	↑ 5.19%
Net Income	$-102.6M	↓ 10.75%
Net Profit Margin	-57.91%	↑ 10.33%

	Q3 FY24	Q/Q Change
Revenue	$191.5M	↑ 8.04%
Net Income	$-107.8M	↑ 4.99%
Net Profit Margin	-56.28%	↑ 1.63%

	FY18	Y/Y Change
Profit	$47.4M	↑ 160.26%

	FY19	Y/Y Change
Profit	$143.7M	↑ 202.88%

	FY20	Y/Y Change
Profit	$194.2M	↑ 35.18%

	FY21	Y/Y Change
Profit	$250.7M	↑ 29.12%

	FY22	Y/Y Change
Profit	$293.2M	↑ 16.94%

	FY23	Y/Y Change
Profit	$336.9M	↑ 14.9%

	Q2 FY23	Q/Q Change
Profit	$83.3M	↑ 10.13%

	Q3 FY23	Q/Q Change
Profit	$85.4M	↑ 2.54%

	Q4 FY23	Q/Q Change
Profit	$236.2M	↑ 176.52%

	Q1 FY24	Q/Q Change
Profit	$103.2M	↓ 56.31%

	Q2 FY24	Q/Q Change
Profit	$104.8M	↑ 1.57%

	Q3 FY24	Q/Q Change
Profit	$117.0M	↑ 11.61%

	FY18	Y/Y Change
Operating Cash Flow	$-72.2M	↓ 0.07%
Investing Cash Flow	$-153.0M	↓ 10.2%
Financing Cash Flow	$293.2M	↑ 4.08%

	FY19	Y/Y Change
Operating Cash Flow	$-47.1M	↓ 34.7%
Investing Cash Flow	$-317.6M	↑ 107.52%
Financing Cash Flow	$367.3M	↑ 25.29%

	FY20	Y/Y Change
Operating Cash Flow	$-103.9M	↑ 120.49%
Investing Cash Flow	$-617.1M	↑ 94.31%
Financing Cash Flow	$1.4B	↑ 283.96%

	FY21	Y/Y Change
Operating Cash Flow	$-209.0M	↑ 101.12%
Investing Cash Flow	$-63.2M	↓ 89.77%
Financing Cash Flow	$-66.8M	↓ 104.74%

	FY22	Y/Y Change
Operating Cash Flow	$-309.5M	↑ 48.06%
Investing Cash Flow	$149.8M	↓ 337.22%
Financing Cash Flow	$-189.1M	↑ 182.97%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-94.0M	↑ 26.29%
Investing Cash Flow	$-241.1M	↓ 253.37%
Financing Cash Flow	$383.9M	↓ 45047.78%

Guardant Health Technicals Summary

Sell

Neutral

Buy

Guardant Health is currently in a neutral trading position according to technical analysis indicators.

Guardant Health (GH) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Guardant Health, Inc.	47.88%	53.78%	111.72%	-33.36%	-40.08%
Agilent Technologies Inc.	13.56%	12.49%	13.95%	5.05%	84.44%
Idexx Laboratories, Inc.	3.23%	-7.26%	-19.94%	-21.0%	53.04%
Thermo Fisher Scientific, Inc.	14.39%	-0.05%	8.32%	-1.06%	87.77%
Danaher Corp.	-3.08%	-17.3%	-9.58%	-24.35%	38.35%
Iqvia Holdings Inc.	3.2%	-13.82%	-4.46%	-20.86%	29.7%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Guardant Health, Inc.	NA	NA	NA	-1.99	-6.09	-0.16	NA	-0.49
Agilent Technologies Inc.	34.13	34.13	2.55	5.57	0.25	0.08	0.0	20.53
Idexx Laboratories, Inc.	41.0	41.0	4.41	10.69	0.59	0.23	NA	19.72
Thermo Fisher Scientific, Inc.	36.77	36.77	2.21	23.34	0.13	0.05	0.0	128.08
Danaher Corp.	42.17	42.17	2.99	7.71	0.08	0.04	0.0	71.03
Iqvia Holdings Inc.	26.46	26.46	1.07	11.12	0.22	0.05	NA	38.37

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Guardant Health, Inc.	Buy	$6.2B	-40.08%	NA	-74.02%
Agilent Technologies Inc.	Buy	$43.3B	84.44%	34.13	21.75%
Idexx Laboratories, Inc.	Buy	$34.7B	53.04%	41.0	22.53%
Thermo Fisher Scientific, Inc.	Buy	$232.1B	87.77%	36.77	14.48%
Danaher Corp.	Buy	$160.4B	38.35%	42.17	16.39%
Iqvia Holdings Inc.	Buy	$36.5B	29.7%	26.46	9.17%

Guardant Health Dividend announcements

Guardant Health Earnings
Guardant Health’s price-to-earnings ratio stands at None
Read More

About Guardant Health

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research; and with ConcertAI to form first data-as-a-service that integrates clinical and tumor profiling data to accelerate cancer therapy research and development. The company was incorporated in 2011 and is headquartered in Palo Alto, California.

Organization	Guardant Health
Employees	1768
CEO	Dr. Helmy Eltoukhy Ph.D.
Industry	Health Services

Management People of Guardant Health

Name	Title
Dr. Helmy Eltoukhy Ph.D.	Co-Founder, Co-CEO & Chairman
Dr. AmirAli Talasaz Ph.D.	Co-CEO & Director
Mr. Michael Bell	Chief Financial Officer
Ms. Darya Chudova	Chief Technology Officer
Dr. Craig Eagle M.D.	Chief Medical Officer
Mr. Christopher Freeman	Chief Commercial Officer
Mr. Kumud Kalia	Chief Information Officer
Zarak Khurshid	Vice President of Investor Relations
Mr. John G. Saia J.D.	Chief Legal Officer & Corporate Secretary
Ms. Jennifer Higgins	Senior Vice President of Public Affairs

Important FAQs about investing in GH Stock from India :

What is Guardant Health share price today?

Guardant Health share price today stands at $46.98, Open: $49.77 ; Previous Close: $49.94 ; High: $49.68 ; Low: $46.76 ; 52 Week High: $50.89 ; 52 Week Low: $15.81.

The stock opens at $49.77, after a previous close of $49.94. The stock reached a daily high of $49.68 and a low of $46.76, with a 52-week high of $50.89 and a 52-week low of $15.81.

Can Indians buy Guardant Health shares?

Yes, Indians can invest in the Guardant Health (GH) from India.

With INDmoney, you can buy Guardant Health at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Guardant Health at zero transaction cost.

How can I buy Guardant Health shares from India?

It is very easy to buy Guardant Health from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Guardant Health (GH) be purchased?

Yes, you can buy fractional shares of Guardant Health with INDmoney app.

What are the documents required to start investing in Guardant Health stocks?

To start investing in Guardant Health, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.